105 related articles for article (PubMed ID: 7452681)
21. Proceedings: Animal experiments of a new synthetic thrombin-inhibitor, dansyl-arginine-methyl-piperidine amide.
Hijikate A; Okamoto S; Ikezawa K; Kikimoto R; Tonomura S; Tamao Y
Thromb Diath Haemorrh; 1975 Sep; 34(1):347-8. PubMed ID: 1188794
[No Abstract] [Full Text] [Related]
22. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
[TBL] [Abstract][Full Text] [Related]
23. The inhibitory effects of N2-dansyl-L-arginine-4-t-butylpiperidine amide (TI233) on contraction of vascular and intestinal smooth muscle.
Karaki H; Murakami K; Nakagawa H; Urakawa N
Br J Pharmacol; 1983 Nov; 80(3):519-25. PubMed ID: 6640205
[TBL] [Abstract][Full Text] [Related]
24. [Synthesis of N-alpha-(arylsulfonyl)-4-amidino-phenylalanyl-prolines and N-alpha-(arylsulfonylglycyl)-4-amidino-phenylalanyl-prolines and testing of them as inhibitors of serine proteinases. 33. Synthetic inhibitors of serine proteinases].
Voigt B; Stürzebecher J; Wagner G; Markwardt F
Pharmazie; 1988 Jun; 43(6):412-4. PubMed ID: 2974999
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory action of two thrombin inhibitors (TI-189 and TI-233) on the contractile responses to 5-hydroxytryptamine and prostaglandin endoperoxide analogue (U-44069) in isolated vascular strips.
Ho WK; Nakao K; Shibata S
Br J Pharmacol; 1980; 71(2):399-405. PubMed ID: 7225193
[TBL] [Abstract][Full Text] [Related]
26. Effects of L- and D-arginine and some related esters on the cytosolic mechanisms of alpha-thrombin-induced human platelet activation.
Failli P; Cecchi E; Ruocco C; Fazzini A; Giotti A
Br J Pharmacol; 1993 Sep; 110(1):213-8. PubMed ID: 8220881
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
[TBL] [Abstract][Full Text] [Related]
28. The interaction of alpha-N-(p-toluenesulphonyl)-p-guanidino-L-phenylalanine methyl ester with thrombin and trypsin.
Klausner YS; Rigbi M; Ticho T; De Jong PJ; Neginsky EJ; Rinott Y
Biochem J; 1978 Jan; 169(1):157-67. PubMed ID: 629742
[TBL] [Abstract][Full Text] [Related]
29. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
Kaiser B; Hauptmann J; Markwardt F
Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of hydrolysis of peptide thioester derivatives of arginine by human and bovine thrombins.
Cook RR; McRae BJ; Powers JC
Arch Biochem Biophys; 1984 Oct; 234(1):82-8. PubMed ID: 6486828
[TBL] [Abstract][Full Text] [Related]
31. Progressive development of a thrombin inhibitor binding site.
Hibbard LS; Nesheim ME; Mann KG
Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
[TBL] [Abstract][Full Text] [Related]
32. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
[TBL] [Abstract][Full Text] [Related]
33. [Synthetic inhibitors of serine proteinases. Part 24: Inhibition of trypsin, plasmin and thrombin by cyclic amides of N alpha-arylsulfonylamidinophenyl-glycines (author's transl)].
Stürzebecher J; Markwardt F; Voigt B; Wagner G; Walsmann P
Pharmazie; 1981; 36(7):501-2. PubMed ID: 6456466
[TBL] [Abstract][Full Text] [Related]
34. Proceedings: A series of extremely potent thrombin-inhibitors newly synthetized.
Okamoto S; Hijikata A; Kikumoto R; Tonomura S; Tamao Y
Thromb Diath Haemorrh; 1975 Sep; 34(1):364-5. PubMed ID: 1188831
[No Abstract] [Full Text] [Related]
35. Comparative studies on thrombin inhibitors in experimental microthrombosis.
Markwardt F; Nowak G; Hoffmann J
Thromb Haemost; 1983 Jun; 49(3):235-7. PubMed ID: 6603675
[TBL] [Abstract][Full Text] [Related]
36. [Synthesis of N-alpha-(arylsulfonylglycyl)amidinophenylalanine amides as highly active inhibitors of thrombin].
Wagner G; Voigt B; Vieweg H
Pharmazie; 1984 Apr; 39(4):226-30. PubMed ID: 6739525
[TBL] [Abstract][Full Text] [Related]
37. Interaction of alpha, beta-diethyl stilbestrol 4,4'-bisphosphate with arginyl substrates resulting in apparent inhibition of trypsin and thrombin.
Steven FS; Griffin MM; Hulley TP; Brooman P
Eur J Biochem; 1982 Jul; 125(2):305-9. PubMed ID: 7117235
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivatives.
Lewis SD; Ng AS; Lyle EA; Mellott MJ; Appleby SD; Brady SF; Stauffer KJ; Sisko JT; Mao SS; Veber DF
Thromb Haemost; 1995 Oct; 74(4):1107-12. PubMed ID: 8560421
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
Cancer Res; 1981 Nov; 41(11 Pt 1):4535-9. PubMed ID: 7306974
[TBL] [Abstract][Full Text] [Related]
40. Selective production of endothelium-derived nitric oxide in canine femoral veins.
Miller VM
Am J Physiol; 1991 Sep; 261(3 Pt 2):H677-82. PubMed ID: 1679603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
